🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AmCad BioMed Corporation (TPEX:4188)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.05
-1.10 (-9.05%)
Nov 20, 2026, 1:30 PM CST

AmCad BioMed Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
26.1630.4453.1165.2661.6385.79
Revenue Growth
-39.87%-42.69%-18.62%5.88%-28.16%34.17%
Cost of Revenue
20.320.4120.1724.2323.5825.13
Gross Profit
5.8710.0232.9341.0238.0560.67
Selling, General & Admin
47.3250.8753.8250.8948.3946.59
Research & Development
49.1147.1143.7844.125450.95
Operating Expenses
96.4397.9897.695.01102.3497.44
Operating Income
-90.57-87.96-64.66-53.99-64.3-36.77
Interest Expense
-0.26-0.09-0.18-0.12-0.12-0.14
Interest & Investment Income
9.169.36.184.714.723.73
Currency Exchange Gain (Loss)
-0.23-0.230.020.091.71.98
Other Non Operating Income (Expenses)
9.657.315.936.323.664.38
EBT Excluding Unusual Items
-72.26-71.67-52.72-42.98-54.35-26.82
Gain (Loss) on Sale of Investments
0.460.460.0300.020
Gain (Loss) on Sale of Assets
-0.22-0.22-0.19-0.17-0.01-0.08
Other Unusual Items
0.020.02-0--
Pretax Income
-71.99-71.4-52.88-43.15-54.34-26.89
Income Tax Expense
0.01-0.02----
Earnings From Continuing Operations
-72-71.39-52.88-43.15-54.34-26.89
Minority Interest in Earnings
16.3715.672.3-2.170.861.35
Net Income
-55.64-55.72-50.58-45.31-53.49-25.54
Net Income to Common
-55.64-55.72-50.58-45.31-53.49-25.54
Net Income Growth
------
Shares Outstanding (Basic)
636358535353
Shares Outstanding (Diluted)
636358535353
Shares Change
0.09%9.75%8.42%0.01%-0.09%
EPS (Basic)
-0.88-0.88-0.88-0.85-1.01-0.48
EPS (Diluted)
-0.88-0.88-0.88-0.85-1.01-0.48
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-51.98-47.44-54.57-41.89-34.81-41.3
Free Cash Flow Per Share
-0.82-0.75-0.95-0.79-0.65-0.78
Gross Margin
22.42%32.93%62.02%62.87%61.73%70.71%
Operating Margin
-346.18%-288.97%-121.77%-82.73%-104.33%-42.86%
Profit Margin
-212.67%-183.06%-95.24%-69.44%-86.79%-29.78%
Free Cash Flow Margin
-198.67%-155.85%-102.76%-64.20%-56.48%-48.14%
EBITDA
-79.89-77.48-51.94-41.26-51.48-23.46
EBITDA Margin
--254.57%-97.81%-63.22%-83.52%-27.35%
D&A For EBITDA
10.6710.4712.7212.7312.8213.31
EBIT
-90.57-87.96-64.66-53.99-64.3-36.77
EBIT Margin
--288.97%-121.77%-82.73%-104.33%-42.86%